Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0O6QO
|
||||
Former ID |
DNC009734
|
||||
Drug Name |
OSIP-339391
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [467742] | ||
Structure |
Download2D MOL |
||||
Formula |
C30H35N7O2
|
||||
InChI |
InChI=1S/C30H35N7O2/c1-22(38)31-14-15-32-28-25-21-26(33-29(25)35-27(34-28)24-12-6-3-7-13-24)30(39)37-19-17-36(18-20-37)16-8-11-23-9-4-2-5-10-23/h2-7,9-10,12-13,21H,8,11,14-20H2,1H3,(H,31,38)(H2,32,33,34,35)
|
||||
InChIKey |
MIUCZFWBCFZKEU-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Adenosine A3 receptor | Target Info | Inhibitor | [530966] | |
Adenosine A2a receptor | Target Info | Inhibitor | [530966] | ||
Adenosine A2b receptor | Target Info | Inhibitor | [530966] | ||
Adenosine A1 receptor | Target Info | Inhibitor | [530966] | ||
KEGG Pathway | Rap1 signaling pathway | ||||
Calcium signaling pathway | |||||
cAMP signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Vascular smooth muscle contraction | |||||
Parkinson's disease | |||||
Alcoholismhsa04015:Rap1 signaling pathway | |||||
Alcoholismhsa04022:cGMP-PKG signaling pathway | |||||
Sphingolipid signaling pathway | |||||
Morphine addiction | |||||
Pathway Interaction Database | HIF-2-alpha transcription factor networkcmyb_pathway:C-MYB transcription factor network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.